Nailfold capillaroscopy, currently used to diagnosis scleroderma, dermatomyositis and antisynthetase myositis, appears to have some prognostic value as well. According to a study of 152 patients from the South Australian Scleroderma Register between 1991 and 2015, nailfold capillary drop out was significantly associated with increased mortality. Professor Peter Roberts-Thomson, from the immunology department at Flinders ...
Simple diagnostic test for scleroderma also useful for prognosis
By Mardi Chapman
1 Feb 2018